7:00 AM ET
8-K
Reverse Stock Split
Moleculin Biotech Reverse Stock Split
Moleculin Biotech announced a 1-for-20 reverse stock split of its common stock, effective October 20, 2026. The split will reduce the number of outstanding shares from approximately 20.91 million to approximately 1.05 million to satisfy Nasdaq listing requirements. The company's common stock will continue to trade under the ticker 'MBRX' with a new CUSIP number.